MacroGenics (MGNX) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free MGNX Stock Alerts $14.37 -1.33 (-8.47%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMacroGenics (NASDAQ:MGNX) Trading Down 9%marketbeat.com - April 25 at 7:46 PMMacroGenics, Inc. (NASDAQ:MGNX) Shares Sold by Federated Hermes Inc.marketbeat.com - April 25 at 5:34 AMMacroGenics, Inc. (MGNX)finance.yahoo.com - April 21 at 8:23 AMWe're Hopeful That MacroGenics (NASDAQ:MGNX) Will Use Its Cash Wiselyfinance.yahoo.com - April 19 at 10:59 AMMacroGenics, Inc. (MGNX) Interactive Stock Chart - Yahoo Financeca.finance.yahoo.com - April 18 at 8:22 AMBuy Rating Affirmed for MacroGenics with Promising Vobra Duo Data and Anticipated 2024 Clarificationsmarkets.businessinsider.com - April 10 at 7:21 PMValidea Detailed Fundamental Analysis - MGNXnasdaq.com - April 10 at 12:40 AMMacroGenics (NASDAQ:MGNX) Upgraded by TD Cowen to "Buy"marketbeat.com - April 9 at 8:30 AMJeffrey Stuart Peters Sells 51,395 Shares of MacroGenics, Inc. (NASDAQ:MGNX) Stockinsidertrades.com - April 9 at 5:04 AMMacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of "Moderate Buy" by Brokeragesmarketbeat.com - April 9 at 2:45 AMMacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidateuk.investing.com - April 6 at 12:52 PMMacroGenics (NASDAQ:MGNX) Shares Up 4.7%marketbeat.com - April 5 at 12:51 PMMacroGenics: Positive Safety Update Leads To Two Major Inflection Points In 2024seekingalpha.com - April 5 at 2:31 AMMacroGenics (NASDAQ:MGNX) Shares Gap Up to $13.67marketbeat.com - April 4 at 1:20 PMBuy Rating Affirmed for MacroGenics on Strong Safety Profile and Anticipated Efficacy Datamarkets.businessinsider.com - April 4 at 1:02 PMThe Latest Analyst Ratings For Macrogenicsmarkets.businessinsider.com - April 4 at 1:02 PMMacroGenics (NASDAQ:MGNX) Stock Rating Reaffirmed by JMP Securitiesmarketbeat.com - April 4 at 9:15 AMSimulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Sessionmarkets.businessinsider.com - April 4 at 8:02 AMMacroGenics gains after mid-stage data for antibody drug conjugatemsn.com - April 4 at 8:02 AMPositive Outlook for MacroGenics: Buy Rating Affirmed Amid Vobra-duo Developmentsmarkets.businessinsider.com - April 4 at 2:05 AMMacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosuresglobenewswire.com - April 3 at 4:30 PMMacroGenics (NASDAQ:MGNX) Stock Price Down 3.6%marketbeat.com - March 28 at 4:33 PMMGNX Apr 2024 10.000 putfinance.yahoo.com - March 16 at 3:33 AMMGNX Dec 2024 17.500 putfinance.yahoo.com - March 16 at 3:33 AMMGNX Mar 2024 22.500 putca.finance.yahoo.com - March 15 at 2:30 AMMacroGenics, Inc. (NASDAQ:MGNX) Short Interest Down 21.3% in Februarymarketbeat.com - March 14 at 3:35 PMThe Potential of MacroGenics’ (NASDAQ:MGNX) Pipeline is Driving the Stockmsn.com - March 14 at 9:30 AMMacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - March 14 at 9:30 AMMacroGenics (NASDAQ:MGNX) Stock Price Down 4.9%marketbeat.com - March 13 at 2:16 PMMacroGenics price target raised by $6 at JMP Securities, here's whyrealmoney.thestreet.com - March 11 at 1:22 PM3 Best Stocks to Buy Now, 3/11/2024, According to Top Analystsmsn.com - March 11 at 8:21 AMMacroGenics price target raised by $12 at Citi, here's whyrealmoney.thestreet.com - March 11 at 8:21 AMMaintaining Market Outperform for MacroGenics with Increased Confidence in ADC Leadership and Clinical Prospectsmarkets.businessinsider.com - March 11 at 8:21 AMBuy Rating Affirmed for MacroGenics on Promising Pipeline and Strong Financialsmarkets.businessinsider.com - March 11 at 8:21 AMMacroGenics (NASDAQ: MGNX)fool.com - March 10 at 7:52 PMGSA Capital Partners LLP Purchases 96,760 Shares of MacroGenics, Inc. (NASDAQ:MGNX)marketbeat.com - March 10 at 7:49 AMMacroGenics (NASDAQ:MGNX) Issues Earnings Resultsmarketbeat.com - March 8 at 11:54 AMMacroGenics (MGNX) Q4 2023 Earnings Call Transcriptfool.com - March 8 at 8:20 AMMGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023msn.com - March 7 at 10:57 PMMacrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ...finance.yahoo.com - March 7 at 10:57 PMMacrogenics: Q4 Earnings Insightsbenzinga.com - March 7 at 5:55 PMMacroGenics GAAP EPS of -$0.15 misses by $0.58, revenue of $58.8M misses by $22.08Mmsn.com - March 7 at 5:55 PMMacroGenics Provides Update on Corporate Progress and 2023 Financial Resultsglobenewswire.com - March 7 at 4:01 PMInsider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX)finance.yahoo.com - March 7 at 2:54 AMMacroGenics Q4 2023 Earnings Previewmsn.com - March 6 at 9:53 PMAnalyst Expectations For Macrogenics's Futurebenzinga.com - March 4 at 7:55 PMMacroGenics (NASDAQ:MGNX) Shares Gap Up Following Analyst Upgrademarketbeat.com - March 4 at 10:31 AMMacroGenics (NASDAQ:MGNX) Given New $24.00 Price Target at BTIG Researchmarketbeat.com - March 4 at 8:25 AMMacroGenics price target raised by $12 at BTIG, here's whyrealmoney.thestreet.com - March 4 at 8:13 AMConnor Clark & Lunn Investment Management Ltd. Makes New Investment in MacroGenics, Inc. (NASDAQ:MGNX)marketbeat.com - March 4 at 6:03 AM Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. MGNX Media Mentions By Week MGNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGNX News Sentiment▼0.540.41▲Average Medical News Sentiment MGNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGNX Articles This Week▼52▲MGNX Articles Average Week Get MacroGenics News Delivered to You Automatically Sign up to receive the latest news and ratings for MGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Belite Bio News Liquidia News MannKind News Immunome News Centessa Pharmaceuticals News Arcutis Biotherapeutics News Mirum Pharmaceuticals News Prothena News Sage Therapeutics News Xencor News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGNX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MacroGenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
